Maravai LifeSciences Holdings, Inc. (MRVI) Net income 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$130.8MFY2025 · since FY2019: -$4.5M → -$130.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$130.8M | +9.7% |
| FY2024 | -$144.8M | -21.7% |
| FY2023 | -$119.0M | -154.1% |
| FY2022 | $220.2M | +21.0% |
| FY2021 | $182.0M | +104.6% |
| FY2020 | $89.0M | +2090.4% |
| FY2019 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRVI financial trends
MRVI RevenueMRVI Net marginMRVI Gross profitMRVI Gross marginMRVI Operating incomeMRVI Operating marginMRVI Operating cash flowMRVI Free cash flowMRVI Capital expendituresMRVI Return on equityMRVI Stock buybacksMRVI Dividends paidMRVI Total assetsMRVI Total liabilitiesMRVI Shareholders’ equityMRVI overview →